Having spent the majority of my career in the life sciences industry, I often hear the personal stories of those impacted by medical innovation. So many families, including mine, are living it. My daughter has Type I diabetes and relies on technology to avert life-threatening low blood sugar levels and related complications. Each story I hear is so uniquely powerful, and serves as a reminder of the importance of continued innovation to society and patients everywhere.
Opioid addiction claims the life of one American every 19 minutes. A rapidly escalating epidemic, the rise in drug addiction is fueling one of the most pressing health crises of the 21st century, and certainly one of the most complex health problems I’ve seen in my lifetime.
But how do we address the problem? There is much public dialogue and debate surrounding this very question. Solutions are being discussed, changes in policy are being proposed and all the while millions of American lives are hanging in the balance.
Stroke is the fifth leading cause of death in the United States and the top cause of disability; thus representing a significant public health problem worldwide. According to the Centers for Disease Control and Prevention (CDC), each year, approximately 800,000 people in the U.S. suffer a stroke.
Stroke from blockage of major blood vessels, known as acute ischemic stroke, causes lasting brain damage and is devastating to patients. This type of stroke becomes a ready-made target for procedures that reopen the vessel and restore blood flow easily performed using “endovascular” (from within the blood stream) techniques. Cerebrovascular and endovascular neurosurgeons have long been at the forefront of these type of procedures.